Cargando…

The Epigenetic Enzyme KMT2A/MLL1 Is a Driver of Coronavirus-associated Coagulopathy

Detalles Bibliográficos
Autores principales:	Sharma, Sriganesh B., Melvin, William J., Audu, Christopher O., Kanthi, Yogendra, Knight, Jason S., Rhoads, Nicole, Adili, Reheman, Holinstat, Michael A., Moore, Bethany B., Henke, Peter K., Wakefield, Thomas W., Gallagher, Katherine A., Obi, Andrea T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187508/ http://dx.doi.org/10.1016/j.jvssci.2022.05.005

Ejemplares similares

The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation
por: Sharma, Sriganesh B., et al.
Publicado: (2023)

Mitigation of SARS-CoV2-Mediated Endothelial Injury via Suppression of the Epigenetic Enzyme KMT2A/MLL1 in Macrophages
por: Sharma, Sriganesh, et al.
Publicado: (2022)

COVID–19-associated coagulopathy: An exploration of mechanisms
por: Colling, Meaghan E, et al.
Publicado: (2020)

MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia
por: Rabello, Doralina do Amaral, et al.
Publicado: (2018)

Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice
por: He, Hongliang, et al.
Publicado: (2020)

Evaluation of receptor‐ligand mechanisms of dual‐targeted particles to an inflamed endothelium
por: Fromen, Catherine A., et al.
Publicado: (2016)

Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
por: Tsakaneli, Alexia, et al.
Publicado: (2021)

Structure, Activity and Function of the MLL2 (KMT2B) Protein Lysine Methyltransferase
por: Klonou, Alexia, et al.
Publicado: (2021)

Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions
por: Meyer, Claus, et al.
Publicado: (2019)

Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice
por: Adili, Reheman, et al.
Publicado: (2021)

Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience
por: Richard-Carpentier, Guillaume, et al.
Publicado: (2021)

DNA fragility at the KMT2A/MLL locus: insights from old and new technologies
por: Cowell, Ian G., et al.
Publicado: (2023)

The lysine‐specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer
por: Rampias, Theodoros, et al.
Publicado: (2019)

KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary
por: Hillman, R. Tyler, et al.
Publicado: (2018)

Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass
por: Bao, Haiyan, et al.
Publicado: (2019)

Deformable microparticles for shuttling nanoparticles to the vascular wall
por: Fish, Margaret B., et al.
Publicado: (2021)

Three de novo variants in KMT2A (MLL) identified by whole exome sequencing in patients with Wiedemann–Steiner syndrome
por: Luo, Sukun, et al.
Publicado: (2021)

Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements
por: Esposito, Maria Teresa, et al.
Publicado: (2022)

Tyrosine kinases in KMT2A/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistance
por: Uckun, Fatih M., et al.
Publicado: (2022)

Development of activated endothelial targeted high-density lipoprotein nanoparticles
por: Yu, Minzhi, et al.
Publicado: (2022)

Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome
por: Knight, Jason S., et al.
Publicado: (2022)

Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis
por: Duan, Xin, et al.
Publicado: (2021)

Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2
por: Melvin, William J., et al.
Publicado: (2021)

Protein kinase Msk1 physically and functionally interacts with the KMT2A/MLL1 methyltransferase complex and contributes to the regulation of multiple target genes
por: Wiersma, Maaike, et al.
Publicado: (2016)

Mutation of cancer driver MLL2 results in transcription stress and genome instability
por: Kantidakis, Theodoros, et al.
Publicado: (2016)

De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing
por: Strom, Samuel P, et al.
Publicado: (2014)

SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
por: Kumar, Nitin, et al.
Publicado: (2021)

GPR56/ADGRG1 is a platelet collagen-responsive GPCR and hemostatic sensor of shear force
por: Yeung, Jennifer, et al.
Publicado: (2020)

Epigenetic control of gene expression in leukemogenesis: Cooperation between wild type MLL and MLL fusion proteins
por: Ballabio, Erica, et al.
Publicado: (2014)

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis
por: Ballabio, Erica, et al.
Publicado: (2012)

Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors
por: Dhar, Shilpa S., et al.
Publicado: (2021)

Clustered PHD domains in KMT2/MLL proteins are attracted by H3K4me3 and H3 acetylation-rich active promoters and enhancers
por: Stroynowska-Czerwinska, Anna Maria, et al.
Publicado: (2023)

The MLL/SET family and haematopoiesis()
por: Antunes, Eric T.B., et al.
Publicado: (2020)

Cargo-free particles divert neutrophil-platelet aggregates to reduce thromboinflammation
por: Banka, Alison L., et al.
Publicado: (2023)

Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics
por: Tourdot, Benjamin E., et al.
Publicado: (2018)

Smart thrombosis inhibitors without bleeding side effects via charge tunable ligand design
por: La, Chanel C., et al.
Publicado: (2023)

The interplay between neutrophils, complement, and microthrombi in COVID-19
por: Zuo, Yu, et al.
Publicado: (2021)

MLL1/WDR5 complex in leukemogenesis and epigenetic regulation
por: Wu, Min, et al.
Publicado: (2011)

MLL1 promotes myogenesis by epigenetically regulating Myf5
por: Cai, Shufang, et al.
Publicado: (2019)

Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
por: Chan, Anthony K. N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6br7d71vp40jkmmumh0mlof9b6